XML 57 R47.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements and Investments - Schedule of Reconciliation For Contingent Consideration Measured At Fair Value Using Significant Unobservable Inputs (Level 3) (Detail) - Neo Medical [Member] - Fair Value, Inputs, Level 3 [Member] - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]    
Fair value of convertible loans beginning balance $ 7,140 $ 7,148
Interest recognized in interest income, net 116 112
Foreign currency remeasurement recognized in other expense, net (61) (69)
Unrealized loss recognized in other comprehensive loss (137) (740)
Conversion of Second Convertible Loan into preferred equity securities   (671)
Fair value of convertible loans ending balance 7,180 5,780
Amortized cost basis of Neo Medical Convertible Loans at March 31 $ 6,084 $ 5,581